Latest On Intra-Cellular Therapies, Inc (ITCI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 22:23 EST | News | Intra-Cellular Therapies: Depression Data Boosts Investment Prospects (Rating Upgrade) | N/A |  |
| 2023-05-05 02:14 EST | News | Intra-Cellular Therapies, Inc. (ITCI) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-04 13:18 EST | News | Intra-Cellular Therapies GAAP EPS of -$0.46 beats by $0.16, revenue of $95.31M beats by $2.9M | N/A | |
| 2023-05-04 00:56 EST | News | Intra-Cellular Therapies Q1 2023 Earnings Preview | N/A | |
| 2023-04-20 22:21 EST | News | Morgan Stanley starts Intra-Cellular at Overweight on schizophrenia therapy | N/A | |
| 2023-03-29 14:05 EST | News | Intra-Cellular Therapies: Increased Confidence In MDD After Study 403 Success | N/A | |
| 2023-03-28 23:19 EST | News | Intra-Cellular jumps 14% after early data for depression candidate | N/A | |
| 2023-03-06 00:14 EST | News | Intra-Cellular's Caplyta Is Likely A Blockbuster For Bipolar Depression Barring Generic Entry | N/A | |
| 2023-03-01 12:26 EST | News | Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M | N/A | |
| 2023-03-01 12:25 EST | News | Intra-Cellular Therapies, Inc. (ITCI) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 21:36 EST | News | Intra-Cellular Therapies Q4 2022 Earnings Preview | N/A | |
| 2022-12-19 03:14 EST | News | Intra-Cellular: Hitting A Growth Inflection (Rating Upgrade) | N/A | |
| 2022-11-04 04:11 EST | News | Intra-Cellular stock surges 11% as bipolar depression drug sales skyrockets in Q3 | N/A | |
| 2022-11-04 04:11 EST | News | Intra-Cellular Therapies, Inc. (ITCI) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-03 10:49 EST | News | Intra-Cellular Therapies GAAP EPS of -$0.57 beats by $0.25, revenue of $71.9M beats by $5.9M | N/A | |
| 2022-11-02 18:55 EST | News | Intra-Cellular Therapies Q3 2022 Earnings Preview | N/A | |
| 2022-09-21 10:03 EST | News | Intra-Cellular Therapies: What Lies Ahead | N/A | |
| 2022-08-23 04:45 EST | News | Intra-Cellular cut to Neutral at Goldman on trends for antipsychotic drug | N/A | |
| 2022-08-10 01:48 EST | News | Intra-Cellular Therapies GAAP EPS of -$0.92 misses by $0.15, revenue of $55.6M beats by $6.98M | N/A | |
| 2022-08-10 01:47 EST | News | Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 03:59 EST | News | Intra-Cellular Therapies Q2 2022 Earnings Preview | N/A | |
| 2022-07-08 05:13 EST | News | BioXcel, Athira gain as Mizuho launches coverage on SMID cap neuro names | N/A | |
| 2022-06-18 08:45 EST | News | Intra-Cellular Therapies: A Dramatic Story | N/A | |
| 2022-06-14 18:06 EST | News | Intra-Cellular initiated Buy at UBS on rollout of depression medication | N/A | |
| 2022-05-11 05:04 EST | News | Intra-Cellular Therapies GAAP EPS of -$0.78 beats by $0.15, revenue of $35M beats by $1.48M | N/A | |
| 2022-05-11 05:04 EST | News | Intra-Cellular rises 18% as robust demand for bipolar depression drug drives Q1 beat | N/A | |
| 2022-05-11 05:04 EST | News | Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 07:30 EST | News | Intra-Cellular Therapies Q1 2022 Earnings Preview | N/A | |
| 2022-04-22 13:29 EST | News | Intra-Cellular Therapies initiated at neutral at Piper Sandler on current valuation | N/A | |
| 2022-03-31 12:13 EST | News | Intra-Cellular: Not Participating In A Bear Market | N/A | |
| 2022-03-21 17:49 EST | News | Intra-Cellular Therapies dips as director sells shares worth ~$13.6M | N/A | |
| 2022-03-08 15:23 EST | News | Intra-Cellular; Long-Term To Own With A Few FDA Approvals And Ability To Expand | N/A | |
| 2022-03-02 02:32 EST | News | Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 08:16 EST | News | Intra-Cellular Therapies GAAP EPS of -$1.05 misses by $0.05, revenue of $25.67M beats by $0.74M | N/A | |
| 2022-02-02 04:03 EST | News | New thematic psychedelic ETF hits the market | N/A | |
| 2022-01-22 04:28 EST | News | Why did Intra-Cellular Therapies Stock Jump today? Demand for antipsychotic drug | N/A | |
| 2022-01-21 12:30 EST | News | Intra-Cellular Therapies gains amid insider selling as Needham points to drug uptake | N/A | |
| 2022-01-05 06:19 EST | News | Intra-Cellular Therapies raises $400M via stock offering | N/A | |
| 2022-01-03 22:14 EST | News | Intra-Cellular Therapies slumps 12% amid launch of $400M common stock offering | N/A | |
| 2021-12-23 14:54 EST | News | Intra-Cellular: Unlocking Value With FDA Approval | N/A | |
| 2021-12-21 04:08 EST | News | Intra-Cellular's Second FDA Win Makes It A Great Long-Term Investment | N/A | |
| 2021-12-20 09:23 EST | News | Intra-Cellular Therapies jumps 18% on FDA approval of Caplyta for bipolar depression | N/A | |
| 2021-11-10 10:13 EST | News | Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-08 13:36 EST | News | Intra-Cellular Therapies: A Leader In The Psychiatric Medicine Space | N/A | |
| 2021-11-08 13:36 EST | News | Intra-Cellular Therapies Q3 2021 Earnings Preview | N/A | |
| 2021-09-27 19:36 EST | News | Intra-Cellular reports lumateperone data in late-stage bipolar depression study | N/A | |
| 2021-08-10 06:02 EST | News | Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-09 09:37 EST | News | Intra-Cellular Therapies Q2 Earnings Preview | N/A | |
| 2021-08-09 09:36 EST | News | Intra-Cellular Therapies EPS misses by $0.04, beats on revenue | N/A | |
| 2021-07-21 12:45 EST | News | Intra-Cellular Therapies (ITCI) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow | N/A | |
About Intra-Cellular Therapies, Inc (ITCI):
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also developing lumateperone, which is in Phase 3 clinical trials for the treatment of bipolar depression, as well as to treat autism spectrum disorder, and sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for the treatment of Parkinson's disease and heart failure; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.
General
- Name Intra-Cellular Therapies, Inc
- Symbol ITCI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 383
- Fiscal Year EndDecember
- IPO Date2014-01-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.intracellulartherapies.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 114.12
- Price/Book (Most Recent Quarter) 4.5
- Enterprise Value Revenue 103.34
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.22
- Next Year EPS Estimate -$1.72
- Next Quarter EPS Estimate -$0.83
- Operating Margin -1014%
- Return on Assets -30%
- Return on Equity -53%
- Revenue 22.81 million
- Earnings Per Share -$2.81
- Revenue Per Share $0.32
- Gross Profit -44864187
- Quarterly Earnings Growth 20447.2%
View More
Highlights
- Market Capitalization 2.84 billion
- EBITDA -161484432
- Analyst Target Price $51.38
- Book Value Per Share $8.16
View More
Share Statistics
- Shares Outstanding 80.92 million
- Shares Float 72.79 million
- % Held by Insiders 504%
- % Held by Institutions 86.06%
- Shares Short 6.43 million
- Shares Short Prior Month 6.35 million
- Short Ratio 9.04
- Short % of Float 9%
- Short % of Shares Outstanding 8%
View More
Technicals
- Beta 1.31
- 52 Week High $40.01
- 52 Week Low $12.13
- 50 Day Moving Average 35.87
- 200 Day Moving Average 29.46
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Intra-Cellular Therapies, Inc (ITCI) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Intra-Cellular Therapies, Inc (ITCI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $12.45 million | -$0.76 | -$0.85 | 10.89% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.79 | -$1.00 | 21.3% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.96 | -$0.90 | -6.83% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.73 | -$0.90 | 18.89% |
| 2019-12-31 | 2020-03-02 | $60613 | -$0.74 | -$0.80 | 7.2% |
| 2019-09-30 | 2019-11-05 | $N/A | -$0.63 | -$0.81 | 22.52% |
| 2019-06-30 | 2019-08-07 | $N/A | -$0.68 | -$0.87 | 21.7% |
| 2019-03-31 | 2019-05-08 | $N/A | -$0.63 | -$0.88 | 28.12% |
| 2018-12-31 | 2019-02-27 | $N/A | -$0.75 | -$0.91 | 17.5% |
| 2018-09-30 | 2018-11-07 | $N/A | -$0.76 | -$0.84 | 9.37% |
| 2018-06-30 | 2018-08-02 | $N/A | -$0.68 | -$0.75 | 9.63% |
| 2018-03-31 | 2018-05-03 | $N/A | -$0.65 | -$0.67 | 2.36% |
| 2017-12-31 | 2018-03-01 | $5000 | -$0.56 | -$0.53 | -6.67% |
| 2017-09-30 | 2017-11-08 | $31000 | -$0.53 | -$0.62 | 14% |
| 2017-06-30 | 2017-08-09 | $115000 | -$0.41 | -$0.74 | 44.78% |
| 2017-03-31 | 2017-05-10 | $95000 | -$0.62 | -$0.72 | 14.04% |
| 2016-12-31 | 2017-03-01 | $98000 | -$0.64 | -$0.77 | 16.34% |
| 2016-09-30 | 2016-11-09 | $4362 | -$0.70 | -$0.86 | 18.47% |
| 2016-06-30 | 2016-08-04 | $228000 | -$0.71 | -$0.79 | 9.55% |
| 2016-03-31 | 2016-04-28 | $N/A | -$0.64 | -$0.78 | 17.95% |
| 2015-12-31 | 2016-02-25 | $31000 | -$0.67 | -$0.86 | 21.79% |
| 2015-09-30 | 2015-11-05 | $-57000 | -$0.91 | -$0.70 | -30% |
| 2015-06-30 | 2015-08-05 | $57000 | -$0.61 | -$0.72 | 15.28% |
| 2015-03-31 | 2015-04-30 | $3315 | -$0.72 | -$0.61 | -18.03% |
| 2014-12-31 | 2015-03-12 | $66000 | -$0.52 | -$0.37 | -40.54% |
| 2014-09-30 | 2014-11-03 | $124000 | -$0.22 | -$0.28 | 21.43% |
| 2014-06-30 | 2014-08-12 | $219000 | -$0.15 | -$0.24 | 37.5% |
| 2014-03-31 | 2014-05-05 | $168000 | -$0.17 | -$0.23 | 26.09% |
| 2013-12-31 | 2014-03-25 | $828000 | -$0.30 | -$0.41 | 26.83% |
Intra-Cellular Therapies, Inc (ITCI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Intra-Cellular Therapies, Inc (ITCI) Chart:
Intra-Cellular Therapies, Inc (ITCI) News:
Below you will find a list of latest news for Intra-Cellular Therapies, Inc (ITCI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Intra-Cellular Therapies, Inc (ITCI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 75 | 0 | CALL | 0 | 0 | 136.65 | TRUE | 0 | 0 |
| 2025-04-17 | 80 | 0 | CALL | 0 | 0 | 122.38 | TRUE | 0 | 0 |
| 2025-04-17 | 85 | 0 | CALL | 0 | 0 | 106.34 | TRUE | 0 | 0 |
| 2025-04-17 | 90 | 0 | CALL | 0 | 0 | 96.26 | TRUE | 0 | 0 |
| 2025-04-17 | 95 | 0 | CALL | 0 | 0 | 84.2 | TRUE | 0 | 0 |
| 2025-04-17 | 100 | 31.7 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 105 | 0 | CALL | 0 | 0 | 85.7 | TRUE | 0 | 0 |
| 2025-04-17 | 110 | 0 | CALL | 0 | 0 | 68.09 | TRUE | 0 | 0 |
| 2025-04-17 | 115 | 17.59 | CALL | 10 | 30 | 45.13 | TRUE | 17.59 | 0 |
| 2025-04-17 | 120 | 12.64 | CALL | 10 | 0 | 30.18 | TRUE | 12.64 | 0 |
| 2025-04-17 | 125 | 6.6 | CALL | 0 | 15 | 30.81 | TRUE | 0 | 0 |
| 2025-04-17 | 130 | 1.95 | CALL | 100 | 3997 | 0 | TRUE | 1.95 | 0 |
| 2025-04-17 | 135 | 0.05 | CALL | 0 | 1270 | 5.36 | FALSE | 0 | 0 |
| 2025-04-17 | 140 | 1.75 | CALL | 0 | 10 | 44.2 | FALSE | 0 | 0 |
| 2025-04-17 | 145 | 0 | CALL | 0 | 0 | 56.03 | FALSE | 0 | 0 |
| 2025-04-17 | 150 | 0 | CALL | 0 | 0 | 66.57 | FALSE | 0 | 0 |
| 2025-04-17 | 155 | 0 | CALL | 0 | 0 | 76.19 | FALSE | 0 | 0 |
| 2025-04-17 | 160 | 0 | CALL | 0 | 0 | 85.1 | FALSE | 0 | 0 |
| 2025-04-17 | 165 | 0 | CALL | 0 | 0 | 93.43 | FALSE | 0 | 0 |
| 2025-04-17 | 170 | 0 | CALL | 0 | 0 | 101.26 | FALSE | 0 | 0 |
| 2025-04-17 | 175 | 0 | CALL | 0 | 0 | 108.67 | FALSE | 0 | 0 |
| 2025-04-17 | 180 | 0 | CALL | 0 | 0 | 115.71 | FALSE | 0 | 0 |
| 2025-04-17 | 185 | 0 | CALL | 0 | 0 | 122.41 | FALSE | 0 | 0 |
| 2025-04-17 | 75 | 0 | PUT | 0 | 0 | 202.45 | FALSE | 0 | 0 |
| 2025-04-17 | 80 | 0 | PUT | 0 | 0 | 183.81 | FALSE | 0 | 0 |
| 2025-04-17 | 85 | 0 | PUT | 0 | 0 | 166.21 | FALSE | 0 | 0 |
| 2025-04-17 | 90 | 0 | PUT | 0 | 0 | 149.47 | FALSE | 0 | 0 |
| 2025-04-17 | 95 | 0 | PUT | 0 | 0 | 133.45 | FALSE | 0 | 0 |
| 2025-04-17 | 100 | 0.05 | PUT | 0 | 16 | 48.66 | FALSE | 0 | 0 |
| 2025-04-17 | 105 | 0 | PUT | 0 | 0 | 103.07 | FALSE | 0 | 0 |
| 2025-04-17 | 110 | 0 | PUT | 0 | 0 | 88.43 | FALSE | 0 | 0 |
| 2025-04-17 | 115 | 0 | PUT | 0 | 0 | 73.96 | FALSE | 0 | 0 |
| 2025-04-17 | 120 | 2.3 | PUT | 0 | 100 | 20.95 | FALSE | 0 | 0 |
| 2025-04-17 | 125 | 0.15 | PUT | 0 | 333 | 13.16 | FALSE | 0 | 0 |
| 2025-04-17 | 130 | 0.05 | PUT | 428 | 2807 | 4.87 | FALSE | -0.1 | -0.67 |
| 2025-04-17 | 135 | 3.35 | PUT | 0 | 1 | 16.28 | TRUE | 0 | 0 |
| 2025-04-17 | 140 | 0 | PUT | 0 | 0 | 44.96 | TRUE | 0 | 0 |
| 2025-04-17 | 145 | 0 | PUT | 0 | 0 | 37 | TRUE | 0 | 0 |
| 2025-04-17 | 150 | 0 | PUT | 0 | 0 | 45.77 | TRUE | 0 | 0 |
| 2025-04-17 | 155 | 0 | PUT | 0 | 0 | 50.82 | TRUE | 0 | 0 |
| 2025-04-17 | 160 | 0 | PUT | 0 | 0 | 58.12 | TRUE | 0 | 0 |
| 2025-04-17 | 165 | 0 | PUT | 0 | 0 | 65 | TRUE | 0 | 0 |
| 2025-04-17 | 170 | 0 | PUT | 0 | 0 | 71.53 | TRUE | 0 | 0 |
| 2025-04-17 | 175 | 0 | PUT | 0 | 0 | 77.75 | TRUE | 0 | 0 |
| 2025-04-17 | 180 | 0 | PUT | 0 | 0 | 83.7 | TRUE | 0 | 0 |
| 2025-04-17 | 185 | 0 | PUT | 0 | 0 | 89.41 | TRUE | 0 | 0 |
| 2025-05-16 | 37.5 | 0 | CALL | 0 | 0 | 254.9 | TRUE | 0 | 0 |
| 2025-05-16 | 40 | 0 | CALL | 0 | 0 | 242.3 | TRUE | 0 | 0 |
| 2025-05-16 | 42.5 | 0 | CALL | 0 | 0 | 230.57 | TRUE | 0 | 0 |
| 2025-05-16 | 45 | 0 | CALL | 0 | 0 | 219.6 | TRUE | 0 | 0 |
| 2025-05-16 | 47.5 | 0 | CALL | 0 | 0 | 209.3 | TRUE | 0 | 0 |
| 2025-05-16 | 50 | 0 | CALL | 0 | 0 | 201.84 | TRUE | 0 | 0 |
| 2025-05-16 | 55 | 0 | CALL | 0 | 0 | 183.78 | TRUE | 0 | 0 |
| 2025-05-16 | 60 | 67.3 | CALL | 0 | 6 | 167.44 | TRUE | 0 | 0 |
| 2025-05-16 | 62.5 | 0 | CALL | 0 | 0 | 159.81 | TRUE | 0 | 0 |
| 2025-05-16 | 65 | 0 | CALL | 0 | 0 | 152.5 | TRUE | 0 | 0 |
| 2025-05-16 | 67.5 | 0 | CALL | 0 | 0 | 145.47 | TRUE | 0 | 0 |
| 2025-05-16 | 70 | 0 | CALL | 0 | 0 | 138.71 | TRUE | 0 | 0 |
| 2025-05-16 | 72.5 | 0 | CALL | 0 | 0 | 132.19 | TRUE | 0 | 0 |
| 2025-05-16 | 75 | 52.4 | CALL | 0 | 307 | 125.9 | TRUE | 0 | 0 |
| 2025-05-16 | 77.5 | 8.6 | CALL | 0 | 5 | 119.81 | TRUE | 0 | 0 |
| 2025-05-16 | 80 | 17.1 | CALL | 0 | 1 | 113.91 | TRUE | 0 | 0 |
| 2025-05-16 | 82.5 | 0 | CALL | 0 | 0 | 108.19 | TRUE | 0 | 0 |
| 2025-05-16 | 85 | 42.6 | CALL | 0 | 317 | 102.62 | TRUE | 0 | 0 |
| 2025-05-16 | 87.5 | 0 | CALL | 0 | 0 | 97.2 | TRUE | 0 | 0 |
| 2025-05-16 | 90 | 39.55 | CALL | 0 | 170 | 91.92 | TRUE | 0 | 0 |
| 2025-05-16 | 92.5 | 5.9 | CALL | 0 | 4 | 86.77 | TRUE | 0 | 0 |
| 2025-05-16 | 95 | 5.4 | CALL | 0 | 2 | 81.73 | TRUE | 0 | 0 |
| 2025-05-16 | 97.5 | 0 | CALL | 0 | 0 | 76.79 | TRUE | 0 | 0 |
| 2025-05-16 | 100 | 29.9 | CALL | 0 | 17 | 71.95 | TRUE | 0 | 0 |
| 2025-05-16 | 105 | 24.4 | CALL | 0 | 12 | 62.51 | TRUE | 0 | 0 |
| 2025-05-16 | 110 | 19.22 | CALL | 0 | 4 | 53.33 | TRUE | 0 | 0 |
| 2025-05-16 | 115 | 15.2 | CALL | 0 | 5 | 44.3 | TRUE | 0 | 0 |
| 2025-05-16 | 120 | 10.65 | CALL | 0 | 1 | 35.31 | TRUE | 0 | 0 |
| 2025-05-16 | 125 | 6.2 | CALL | 0 | 2 | 16.64 | TRUE | 0 | 0 |
| 2025-05-16 | 130 | 2.3 | CALL | 1 | 4393 | 0 | TRUE | 2.3 | 0 |
| 2025-05-16 | 135 | 0.05 | CALL | 0 | 20125 | 2.93 | FALSE | 0 | 0 |
| 2025-05-16 | 140 | 0 | CALL | 0 | 0 | 27.03 | FALSE | 0 | 0 |
| 2025-05-16 | 145 | 0 | CALL | 0 | 0 | 34.54 | FALSE | 0 | 0 |
| 2025-05-16 | 150 | 0 | CALL | 0 | 0 | 41.22 | FALSE | 0 | 0 |
| 2025-05-16 | 37.5 | 0.2 | PUT | 0 | 1 | 183.6 | FALSE | 0 | 0 |
| 2025-05-16 | 40 | 0 | PUT | 0 | 0 | 168.29 | FALSE | 0 | 0 |
| 2025-05-16 | 42.5 | 0 | PUT | 0 | 0 | 231.82 | FALSE | 0 | 0 |
| 2025-05-16 | 45 | 0 | PUT | 0 | 0 | 221.15 | FALSE | 0 | 0 |
| 2025-05-16 | 47.5 | 0 | PUT | 0 | 0 | 211.12 | FALSE | 0 | 0 |
| 2025-05-16 | 50 | 0 | PUT | 0 | 0 | 201.66 | FALSE | 0 | 0 |
| 2025-05-16 | 55 | 0 | PUT | 0 | 0 | 113.41 | FALSE | 0 | 0 |
| 2025-05-16 | 60 | 0 | PUT | 0 | 0 | 168.37 | FALSE | 0 | 0 |
| 2025-05-16 | 62.5 | 0 | PUT | 0 | 0 | 160.96 | FALSE | 0 | 0 |
| 2025-05-16 | 65 | 0 | PUT | 0 | 0 | 153.86 | FALSE | 0 | 0 |
| 2025-05-16 | 67.5 | 0 | PUT | 0 | 0 | 147.03 | FALSE | 0 | 0 |
| 2025-05-16 | 70 | 0.3 | PUT | 0 | 10 | 140.45 | FALSE | 0 | 0 |
| 2025-05-16 | 72.5 | 0.15 | PUT | 0 | 371 | 62.12 | FALSE | 0 | 0 |
| 2025-05-16 | 75 | 0.29 | PUT | 0 | 434 | 58.87 | FALSE | 0 | 0 |
| 2025-05-16 | 77.5 | 0 | PUT | 0 | 0 | 122 | FALSE | 0 | 0 |
| 2025-05-16 | 80 | 4.81 | PUT | 0 | 1 | 116.23 | FALSE | 0 | 0 |
| 2025-05-16 | 82.5 | 0.5 | PUT | 0 | 97 | 49.71 | FALSE | 0 | 0 |
| 2025-05-16 | 85 | 0.35 | PUT | 0 | 4802 | 50.66 | FALSE | 0 | 0 |
| 2025-05-16 | 87.5 | 0 | PUT | 0 | 0 | 99.83 | FALSE | 0 | 0 |
| 2025-05-16 | 90 | 0 | PUT | 0 | 0 | 44.73 | FALSE | 0 | 0 |
| 2025-05-16 | 92.5 | 0.05 | PUT | 0 | 15 | 89.54 | FALSE | 0 | 0 |
| 2025-05-16 | 95 | 0 | PUT | 0 | 0 | 84.56 | FALSE | 0 | 0 |
| 2025-05-16 | 97.5 | 0 | PUT | 0 | 0 | 79.67 | FALSE | 0 | 0 |
| 2025-05-16 | 100 | 0.07 | PUT | 0 | 365 | 33.65 | FALSE | 0 | 0 |
| 2025-05-16 | 105 | 0.55 | PUT | 0 | 307 | 65.46 | FALSE | 0 | 0 |
| 2025-05-16 | 110 | 0.1 | PUT | 0 | 111 | 24.77 | FALSE | 0 | 0 |
| 2025-05-16 | 115 | 0.15 | PUT | 0 | 1382 | 19.6 | FALSE | 0 | 0 |
| 2025-05-16 | 120 | 0.1 | PUT | 1 | 2414 | 15.24 | FALSE | 0.1 | 0 |
| 2025-05-16 | 125 | 0.05 | PUT | 486 | 3231 | 8.68 | FALSE | -0.09 | -0.64 |
| 2025-05-16 | 130 | 0.1 | PUT | 26 | 130 | 4.17 | FALSE | 0.05 | 1 |
| 2025-05-16 | 135 | 7.1 | PUT | 0 | 0 | 6.66 | TRUE | 0 | 0 |
| 2025-05-16 | 140 | 0 | PUT | 0 | 0 | 29.24 | TRUE | 0 | 0 |
| 2025-05-16 | 145 | 0 | PUT | 0 | 0 | 38.23 | TRUE | 0 | 0 |
| 2025-05-16 | 150 | 0 | PUT | 0 | 0 | 43.82 | TRUE | 0 | 0 |
| 2025-08-15 | 45 | 0 | CALL | 0 | 0 | 124.51 | TRUE | 0 | 0 |
| 2025-08-15 | 47.5 | 0 | CALL | 0 | 0 | 118.27 | TRUE | 0 | 0 |
| 2025-08-15 | 50 | 0 | CALL | 0 | 0 | 112.39 | TRUE | 0 | 0 |
| 2025-08-15 | 55 | 0 | CALL | 0 | 0 | 101.56 | TRUE | 0 | 0 |
| 2025-08-15 | 60 | 0 | CALL | 0 | 0 | 91.78 | TRUE | 0 | 0 |
| 2025-08-15 | 65 | 0 | CALL | 0 | 0 | 82.85 | TRUE | 0 | 0 |
| 2025-08-15 | 70 | 0 | CALL | 0 | 0 | 74.63 | TRUE | 0 | 0 |
| 2025-08-15 | 75 | 0 | CALL | 0 | 0 | 67.03 | TRUE | 0 | 0 |
| 2025-08-15 | 77.5 | 0 | CALL | 0 | 0 | 63.42 | TRUE | 0 | 0 |
| 2025-08-15 | 80 | 0 | CALL | 0 | 0 | 59.94 | TRUE | 0 | 0 |
| 2025-08-15 | 82.5 | 0 | CALL | 0 | 0 | 56.57 | TRUE | 0 | 0 |
| 2025-08-15 | 85 | 0 | CALL | 0 | 0 | 53.3 | TRUE | 0 | 0 |
| 2025-08-15 | 87.5 | 0 | CALL | 0 | 0 | 50.14 | TRUE | 0 | 0 |
| 2025-08-15 | 90 | 0 | CALL | 0 | 0 | 47.06 | TRUE | 0 | 0 |
| 2025-08-15 | 92.5 | 0 | CALL | 0 | 0 | 44.07 | TRUE | 0 | 0 |
| 2025-08-15 | 95 | 0 | CALL | 0 | 0 | 41.16 | TRUE | 0 | 0 |
| 2025-08-15 | 97.5 | 0 | CALL | 0 | 0 | 38.33 | TRUE | 0 | 0 |
| 2025-08-15 | 100 | 0 | CALL | 0 | 0 | 35.56 | TRUE | 0 | 0 |
| 2025-08-15 | 105 | 22.6 | CALL | 0 | 6 | 30.23 | TRUE | 0 | 0 |
| 2025-08-15 | 110 | 19.8 | CALL | 0 | 5 | 25.13 | TRUE | 0 | 0 |
| 2025-08-15 | 115 | 0 | CALL | 0 | 0 | 20.21 | TRUE | 0 | 0 |
| 2025-08-15 | 120 | 10.3 | CALL | 0 | 15 | 0 | TRUE | 0 | 0 |
| 2025-08-15 | 125 | 7.7 | CALL | 1 | 84 | 0 | TRUE | 0.7 | 0.1 |
| 2025-08-15 | 130 | 3 | CALL | 1 | 126 | 0 | TRUE | 0.1 | 0.03 |
| 2025-08-15 | 135 | 0.05 | CALL | 0 | 1170 | 1.03 | FALSE | 0 | 0 |
| 2025-08-15 | 140 | 0.95 | CALL | 0 | 2 | 14.42 | FALSE | 0 | 0 |
| 2025-08-15 | 145 | 0 | CALL | 0 | 0 | 18.99 | FALSE | 0 | 0 |
| 2025-08-15 | 150 | 0 | CALL | 0 | 0 | 23.01 | FALSE | 0 | 0 |
| 2025-08-15 | 45 | 0 | PUT | 0 | 0 | 78.28 | FALSE | 0 | 0 |
| 2025-08-15 | 47.5 | 0 | PUT | 0 | 0 | 78.96 | FALSE | 0 | 0 |
| 2025-08-15 | 50 | 0 | PUT | 0 | 0 | 119.57 | FALSE | 0 | 0 |
| 2025-08-15 | 55 | 0.35 | PUT | 0 | 9 | 64.7 | FALSE | 0 | 0 |
| 2025-08-15 | 60 | 0.4 | PUT | 0 | 3 | 99.99 | FALSE | 0 | 0 |
| 2025-08-15 | 65 | 0.06 | PUT | 0 | 33 | 91.46 | FALSE | 0 | 0 |
| 2025-08-15 | 70 | 0 | PUT | 0 | 0 | 58.7 | FALSE | 0 | 0 |
| 2025-08-15 | 75 | 0 | PUT | 0 | 0 | 76.24 | FALSE | 0 | 0 |
| 2025-08-15 | 77.5 | 0 | PUT | 0 | 0 | 72.75 | FALSE | 0 | 0 |
| 2025-08-15 | 80 | 0 | PUT | 0 | 0 | 69.36 | FALSE | 0 | 0 |
| 2025-08-15 | 82.5 | 0 | PUT | 0 | 0 | 66.06 | FALSE | 0 | 0 |
| 2025-08-15 | 85 | 0.85 | PUT | 0 | 10 | 62.85 | FALSE | 0 | 0 |
| 2025-08-15 | 87.5 | 0 | PUT | 0 | 0 | 59.73 | FALSE | 0 | 0 |
| 2025-08-15 | 90 | 0 | PUT | 0 | 0 | 26.9 | FALSE | 0 | 0 |
| 2025-08-15 | 92.5 | 0 | PUT | 0 | 0 | 53.69 | FALSE | 0 | 0 |
| 2025-08-15 | 95 | 0 | PUT | 0 | 0 | 50.77 | FALSE | 0 | 0 |
| 2025-08-15 | 97.5 | 0 | PUT | 0 | 0 | 47.9 | FALSE | 0 | 0 |
| 2025-08-15 | 100 | 0.05 | PUT | 32 | 1624 | 20.4 | FALSE | 0.05 | 0 |
| 2025-08-15 | 105 | 0 | PUT | 0 | 0 | 17.34 | FALSE | 0 | 0 |
| 2025-08-15 | 110 | 0.1 | PUT | 1 | 19 | 15.92 | FALSE | 0.1 | 0 |
| 2025-08-15 | 115 | 0.15 | PUT | 53 | 410 | 12.21 | FALSE | -0.05 | -0.25 |
| 2025-08-15 | 120 | 0.15 | PUT | 9 | 9 | 10.44 | FALSE | -0.1 | -0.4 |
| 2025-08-15 | 125 | 0.15 | PUT | 27 | 276 | 7.14 | FALSE | 0.15 | 0 |
| 2025-08-15 | 130 | 0.5 | PUT | 0 | 4 | 3.4 | FALSE | 0 | 0 |
| 2025-08-15 | 135 | 0 | PUT | 0 | 0 | 5.64 | TRUE | 0 | 0 |
| 2025-08-15 | 140 | 0 | PUT | 0 | 0 | 19.88 | TRUE | 0 | 0 |
| 2025-08-15 | 145 | 0 | PUT | 0 | 0 | 25.17 | TRUE | 0 | 0 |
| 2025-08-15 | 150 | 0 | PUT | 0 | 0 | 29.59 | TRUE | 0 | 0 |
| 2025-11-21 | 75 | 0 | CALL | 0 | 0 | 43.54 | TRUE | 0 | 0 |
| 2025-11-21 | 80 | 0 | CALL | 0 | 0 | 37.63 | TRUE | 0 | 0 |
| 2025-11-21 | 85 | 0 | CALL | 0 | 0 | 31.96 | TRUE | 0 | 0 |
| 2025-11-21 | 90 | 0 | CALL | 0 | 0 | 26.36 | TRUE | 0 | 0 |
| 2025-11-21 | 95 | 0 | CALL | 0 | 0 | 20.38 | TRUE | 0 | 0 |
| 2025-11-21 | 100 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 105 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 110 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 115 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 120 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 125 | 7.7 | CALL | 1 | 12 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 130 | 2.9 | CALL | 1 | 6 | 0 | TRUE | 0 | 0 |
| 2025-11-21 | 135 | 0.8 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-11-21 | 140 | 0 | CALL | 0 | 0 | 9.83 | FALSE | 0 | 0 |
| 2025-11-21 | 145 | 0 | CALL | 0 | 0 | 13.47 | FALSE | 0 | 0 |
| 2025-11-21 | 150 | 0 | CALL | 0 | 0 | 16.63 | FALSE | 0 | 0 |
| 2025-11-21 | 155 | 0 | CALL | 0 | 0 | 19.47 | FALSE | 0 | 0 |
| 2025-11-21 | 160 | 0 | CALL | 0 | 0 | 22.09 | FALSE | 0 | 0 |
| 2025-11-21 | 165 | 0 | CALL | 0 | 0 | 24.51 | FALSE | 0 | 0 |
| 2025-11-21 | 170 | 0 | CALL | 0 | 0 | 26.79 | FALSE | 0 | 0 |
| 2025-11-21 | 175 | 0 | CALL | 0 | 0 | 28.93 | FALSE | 0 | 0 |
| 2025-11-21 | 180 | 0 | CALL | 0 | 0 | 30.97 | FALSE | 0 | 0 |
| 2025-11-21 | 185 | 0 | CALL | 0 | 0 | 32.9 | FALSE | 0 | 0 |
| 2025-11-21 | 75 | 0 | PUT | 0 | 0 | 59.22 | FALSE | 0 | 0 |
| 2025-11-21 | 80 | 0 | PUT | 0 | 0 | 53.95 | FALSE | 0 | 0 |
| 2025-11-21 | 85 | 0 | PUT | 0 | 0 | 48.97 | FALSE | 0 | 0 |
| 2025-11-21 | 90 | 0.05 | PUT | 0 | 1 | 21.1 | FALSE | 0 | 0 |
| 2025-11-21 | 95 | 0.05 | PUT | 0 | 8 | 39.73 | FALSE | 0 | 0 |
| 2025-11-21 | 100 | 0 | PUT | 0 | 0 | 35.38 | FALSE | 0 | 0 |
| 2025-11-21 | 105 | 0.1 | PUT | 1 | 0 | 15.19 | FALSE | 0.1 | 0 |
| 2025-11-21 | 110 | 0.1 | PUT | 3 | 7 | 12.74 | FALSE | 0.1 | 0 |
| 2025-11-21 | 115 | 0.15 | PUT | 24 | 11 | 11.08 | FALSE | -0.05 | -0.25 |
| 2025-11-21 | 120 | 0.1 | PUT | 188 | 22 | 7.98 | FALSE | -0.1 | -0.5 |
| 2025-11-21 | 125 | 0.3 | PUT | 0 | 2 | 5.31 | FALSE | 0 | 0 |
| 2025-11-21 | 130 | 0.15 | PUT | 30 | 3 | 3.29 | FALSE | 0.15 | 0 |
| 2025-11-21 | 135 | 0 | PUT | 0 | 0 | 5.35 | TRUE | 0 | 0 |
| 2025-11-21 | 140 | 0 | PUT | 0 | 0 | 16.78 | TRUE | 0 | 0 |
| 2025-11-21 | 145 | 0 | PUT | 0 | 0 | 21.08 | TRUE | 0 | 0 |
| 2025-11-21 | 150 | 0 | PUT | 0 | 0 | 24.36 | TRUE | 0 | 0 |
| 2025-11-21 | 155 | 0 | PUT | 0 | 0 | 27.62 | TRUE | 0 | 0 |
| 2025-11-21 | 160 | 0 | PUT | 0 | 0 | 30.96 | TRUE | 0 | 0 |
| 2025-11-21 | 165 | 0 | PUT | 0 | 0 | 33.79 | TRUE | 0 | 0 |
| 2025-11-21 | 170 | 0 | PUT | 0 | 0 | 36.47 | TRUE | 0 | 0 |
| 2025-11-21 | 175 | 0 | PUT | 0 | 0 | 39.01 | TRUE | 0 | 0 |
| 2025-11-21 | 180 | 0 | PUT | 0 | 0 | 41.42 | TRUE | 0 | 0 |
| 2025-11-21 | 185 | 0 | PUT | 0 | 0 | 43.73 | TRUE | 0 | 0 |
| 2025-12-19 | 37.5 | 0 | CALL | 0 | 0 | 99.57 | TRUE | 0 | 0 |
| 2025-12-19 | 40 | 0 | CALL | 0 | 0 | 93.77 | TRUE | 0 | 0 |
| 2025-12-19 | 42.5 | 43 | CALL | 0 | 0 | 88.37 | TRUE | 0 | 0 |
| 2025-12-19 | 45 | 0 | CALL | 0 | 0 | 83.3 | TRUE | 0 | 0 |
| 2025-12-19 | 47.5 | 0 | CALL | 0 | 0 | 78.52 | TRUE | 0 | 0 |
| 2025-12-19 | 50 | 78 | CALL | 0 | 2 | 74.01 | TRUE | 0 | 0 |
| 2025-12-19 | 55 | 0 | CALL | 0 | 0 | 65.64 | TRUE | 0 | 0 |
| 2025-12-19 | 60 | 0 | CALL | 0 | 0 | 58 | TRUE | 0 | 0 |
| 2025-12-19 | 62.5 | 0 | CALL | 0 | 0 | 54.4 | TRUE | 0 | 0 |
| 2025-12-19 | 65 | 0 | CALL | 0 | 0 | 50.93 | TRUE | 0 | 0 |
| 2025-12-19 | 67.5 | 0 | CALL | 0 | 0 | 47.57 | TRUE | 0 | 0 |
| 2025-12-19 | 70 | 62.27 | CALL | 0 | 10 | 44.3 | TRUE | 0 | 0 |
| 2025-12-19 | 72.5 | 59.43 | CALL | 0 | 0 | 41.1 | TRUE | 0 | 0 |
| 2025-12-19 | 75 | 55.5 | CALL | 0 | 4 | 37.96 | TRUE | 0 | 0 |
| 2025-12-19 | 77.5 | 0 | CALL | 0 | 0 | 34.84 | TRUE | 0 | 0 |
| 2025-12-19 | 80 | 51.51 | CALL | 0 | 61 | 31.69 | TRUE | 0 | 0 |
| 2025-12-19 | 82.5 | 0 | CALL | 0 | 0 | 28.42 | TRUE | 0 | 0 |
| 2025-12-19 | 85 | 45 | CALL | 0 | 8 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 87.5 | 0 | CALL | 0 | 0 | 19.8 | TRUE | 0 | 0 |
| 2025-12-19 | 90 | 19 | CALL | 0 | 6 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 92.5 | 38.63 | CALL | 0 | 5 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 95 | 36.6 | CALL | 0 | 4 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 97.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 100 | 30.4 | CALL | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 105 | 25.69 | CALL | 0 | 70 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 110 | 20.9 | CALL | 0 | 16 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 115 | 15.5 | CALL | 0 | 25 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 120 | 12.35 | CALL | 0 | 208 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 125 | 7.7 | CALL | 1 | 588 | 0 | TRUE | 0.7 | 0.1 |
| 2025-12-19 | 130 | 2.05 | CALL | 5 | 356 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 135 | 0.05 | CALL | 0 | 166 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 140 | 0.05 | CALL | 0 | 55 | 1.84 | FALSE | 0 | 0 |
| 2025-12-19 | 145 | 0 | CALL | 0 | 0 | 12.44 | FALSE | 0 | 0 |
| 2025-12-19 | 150 | 0 | CALL | 0 | 0 | 15.45 | FALSE | 0 | 0 |
| 2025-12-19 | 37.5 | 0.1 | PUT | 0 | 11 | 66.37 | FALSE | 0 | 0 |
| 2025-12-19 | 40 | 0 | PUT | 0 | 0 | 66.81 | FALSE | 0 | 0 |
| 2025-12-19 | 42.5 | 0 | PUT | 0 | 0 | 100.51 | FALSE | 0 | 0 |
| 2025-12-19 | 45 | 0 | PUT | 0 | 0 | 57.36 | FALSE | 0 | 0 |
| 2025-12-19 | 47.5 | 0.3 | PUT | 0 | 1 | 56.92 | FALSE | 0 | 0 |
| 2025-12-19 | 50 | 0.05 | PUT | 0 | 25 | 87.63 | FALSE | 0 | 0 |
| 2025-12-19 | 55 | 0.05 | PUT | 0 | 21 | 51.86 | FALSE | 0 | 0 |
| 2025-12-19 | 60 | 0.05 | PUT | 0 | 466 | 73.44 | FALSE | 0 | 0 |
| 2025-12-19 | 62.5 | 0.5 | PUT | 0 | 3 | 70.28 | FALSE | 0 | 0 |
| 2025-12-19 | 65 | 0.05 | PUT | 0 | 4 | 67.26 | FALSE | 0 | 0 |
| 2025-12-19 | 67.5 | 0.05 | PUT | 0 | 1 | 64.35 | FALSE | 0 | 0 |
| 2025-12-19 | 70 | 9.78 | PUT | 0 | 1 | 61.55 | FALSE | 0 | 0 |
| 2025-12-19 | 72.5 | 0 | PUT | 0 | 0 | 58.84 | FALSE | 0 | 0 |
| 2025-12-19 | 75 | 0.05 | PUT | 0 | 1074 | 28.08 | FALSE | 0 | 0 |
| 2025-12-19 | 77.5 | 0.6 | PUT | 0 | 1 | 53.7 | FALSE | 0 | 0 |
| 2025-12-19 | 80 | 0.05 | PUT | 0 | 3 | 51.24 | FALSE | 0 | 0 |
| 2025-12-19 | 82.5 | 0.05 | PUT | 0 | 2 | 48.86 | FALSE | 0 | 0 |
| 2025-12-19 | 85 | 0 | PUT | 0 | 0 | 46.54 | FALSE | 0 | 0 |
| 2025-12-19 | 87.5 | 0.05 | PUT | 0 | 5 | 44.28 | FALSE | 0 | 0 |
| 2025-12-19 | 90 | 0.05 | PUT | 0 | 4 | 20.09 | FALSE | 0 | 0 |
| 2025-12-19 | 92.5 | 0.05 | PUT | 0 | 16 | 39.91 | FALSE | 0 | 0 |
| 2025-12-19 | 95 | 0.05 | PUT | 0 | 7 | 37.8 | FALSE | 0 | 0 |
| 2025-12-19 | 97.5 | 0.05 | PUT | 0 | 2 | 35.73 | FALSE | 0 | 0 |
| 2025-12-19 | 100 | 0.05 | PUT | 10 | 152 | 15.39 | FALSE | 0.05 | 0 |
| 2025-12-19 | 105 | 0.1 | PUT | 3 | 0 | 14.51 | FALSE | 0.1 | 0 |
| 2025-12-19 | 110 | 0.1 | PUT | 1 | 2098 | 12.19 | FALSE | 0.1 | 0 |
| 2025-12-19 | 115 | 0.15 | PUT | 4 | 5 | 10.64 | FALSE | -0.05 | -0.25 |
| 2025-12-19 | 120 | 0.1 | PUT | 92 | 102 | 7.7 | FALSE | -0.1 | -0.5 |
| 2025-12-19 | 125 | 0.1 | PUT | 146 | 336 | 5.44 | FALSE | -0.15 | -0.6 |
| 2025-12-19 | 130 | 0.25 | PUT | 11 | 83 | 3.75 | FALSE | 0.25 | 0 |
| 2025-12-19 | 135 | 3.2 | PUT | 1 | 0 | 5.31 | TRUE | 3.2 | 0 |
| 2025-12-19 | 140 | 0 | PUT | 0 | 0 | 16.26 | TRUE | 0 | 0 |
| 2025-12-19 | 145 | 0 | PUT | 0 | 0 | 14.15 | TRUE | 0 | 0 |
| 2025-12-19 | 150 | 0 | PUT | 0 | 0 | 23.82 | TRUE | 0 | 0 |
Latest ITCI Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 4 | $53.11 |
| Jun 13, 2022 7:59 PM EST | 3 | $53.08 |
| Jun 13, 2022 7:59 PM EST | 3 | $53.1 |
| Jun 13, 2022 7:59 PM EST | 100 | $53.11 |
| Jun 13, 2022 7:59 PM EST | 100 | $53.08 |
Intra-Cellular Therapies, Inc (ITCI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040693/0001209191-20-040693-index.htm |
| 2019-09-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1567514/000000000019013358/0000000000-19-013358-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000021545719004129/0000215457-19-004129-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000031506619001137/0000315066-19-001137-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000031506620001012/0000315066-20-001012-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000083423720005435/0000834237-20-005435-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000093247119006085/0000932471-19-006085-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000095012320006465/0000950123-20-006465-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000110465920018491/0001104659-20-018491-index.htm |
| 2019-09-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1567514/000114420419046544/0001144204-19-046544-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312518320117/0001193125-18-320117-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312518320973/0001193125-18-320973-index.htm |
| 2018-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312518346578/0001193125-18-346578-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312518347297/0001193125-18-347297-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312518351544/0001193125-18-351544-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519052856/0001193125-19-052856-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519054119/0001193125-19-054119-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1567514/000119312519129381/0001193125-19-129381-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1567514/000119312519129402/0001193125-19-129402-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519140490/0001193125-19-140490-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519141425/0001193125-19-141425-index.htm |
| 2019-06-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1567514/000119312519173721/0001193125-19-173721-index.htm |
| 2019-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519182626/0001193125-19-182626-index.htm |
| 2019-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519189981/0001193125-19-189981-index.htm |
| 2019-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519200473/0001193125-19-200473-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519212533/0001193125-19-212533-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519214665/0001193125-19-214665-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519215347/0001193125-19-215347-index.htm |
| 2019-08-30 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1567514/000119312519234332/0001193125-19-234332-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519241521/0001193125-19-241521-index.htm |
| 2019-09-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1567514/000119312519241970/0001193125-19-241970-index.htm |
| 2019-09-12 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519243978/0001193125-19-243978-index.htm |
| 2019-09-12 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519243984/0001193125-19-243984-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519284066/0001193125-19-284066-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312519284125/0001193125-19-284125-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312519321816/0001193125-19-321816-index.htm |
| 2020-01-06 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1567514/000119312520002156/0001193125-20-002156-index.htm |
| 2020-01-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520002222/0001193125-20-002222-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520002249/0001193125-20-002249-index.htm |
| 2020-01-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520003784/0001193125-20-003784-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520003933/0001193125-20-003933-index.htm |
| 2020-02-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1567514/000119312520026631/0001193125-20-026631-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520057862/0001193125-20-057862-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520057888/0001193125-20-057888-index.htm |
| 2020-03-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1567514/000119312520059034/0001193125-20-059034-index.htm |
| 2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520081568/0001193125-20-081568-index.htm |
| 2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1567514/000119312520102559/0001193125-20-102559-index.htm |
| 2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1567514/000119312520102577/0001193125-20-102577-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520135603/0001193125-20-135603-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520135617/0001193125-20-135617-index.htm |
| 2020-05-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1567514/000119312520141642/0001193125-20-141642-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520154280/0001193125-20-154280-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520214128/0001193125-20-214128-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520214163/0001193125-20-214163-index.htm |
| 2020-08-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1567514/000119312520214933/0001193125-20-214933-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520241518/0001193125-20-241518-index.htm |
| 2020-09-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520242231/0001193125-20-242231-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520242293/0001193125-20-242293-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520243083/0001193125-20-243083-index.htm |
| 2020-09-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1567514/000119312520244185/0001193125-20-244185-index.htm |
| 2020-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520244196/0001193125-20-244196-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1567514/000119312520261367/0001193125-20-261367-index.htm |
| 2018-10-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118055300/0001209191-18-055300-index.htm |
| 2018-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118055308/0001209191-18-055308-index.htm |
| 2018-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118056061/0001209191-18-056061-index.htm |
| 2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118058348/0001209191-18-058348-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118061525/0001209191-18-061525-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919118062061/0001209191-18-062061-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001513/0001209191-19-001513-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001532/0001209191-19-001532-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001545/0001209191-19-001545-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001553/0001209191-19-001553-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001562/0001209191-19-001562-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001584/0001209191-19-001584-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001588/0001209191-19-001588-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001606/0001209191-19-001606-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001611/0001209191-19-001611-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002955/0001209191-19-002955-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002957/0001209191-19-002957-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002960/0001209191-19-002960-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002962/0001209191-19-002962-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002964/0001209191-19-002964-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119003255/0001209191-19-003255-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119003261/0001209191-19-003261-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119015224/0001209191-19-015224-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022712/0001209191-19-022712-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022715/0001209191-19-022715-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022725/0001209191-19-022725-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022737/0001209191-19-022737-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119030123/0001209191-19-030123-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119033664/0001209191-19-033664-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119037205/0001209191-19-037205-index.htm |
| 2019-06-19 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119038093/0001209191-19-038093-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119038098/0001209191-19-038098-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119039107/0001209191-19-039107-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119039114/0001209191-19-039114-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119039116/0001209191-19-039116-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119039119/0001209191-19-039119-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119039121/0001209191-19-039121-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040359/0001209191-19-040359-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040399/0001209191-19-040399-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040436/0001209191-19-040436-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040463/0001209191-19-040463-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119048307/0001209191-19-048307-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119049172/0001209191-19-049172-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051848/0001209191-19-051848-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051853/0001209191-19-051853-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051857/0001209191-19-051857-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051861/0001209191-19-051861-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119053435/0001209191-19-053435-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919119061920/0001209191-19-061920-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001462/0001209191-20-001462-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001463/0001209191-20-001463-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001464/0001209191-20-001464-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002634/0001209191-20-002634-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002637/0001209191-20-002637-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003142/0001209191-20-003142-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003144/0001209191-20-003144-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003146/0001209191-20-003146-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003148/0001209191-20-003148-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003150/0001209191-20-003150-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003756/0001209191-20-003756-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005265/0001209191-20-005265-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005268/0001209191-20-005268-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005270/0001209191-20-005270-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120011303/0001209191-20-011303-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120011308/0001209191-20-011308-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120011314/0001209191-20-011314-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120011316/0001209191-20-011316-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120011318/0001209191-20-011318-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022748/0001209191-20-022748-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022753/0001209191-20-022753-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022760/0001209191-20-022760-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022764/0001209191-20-022764-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120028898/0001209191-20-028898-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120029009/0001209191-20-029009-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120029818/0001209191-20-029818-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120032734/0001209191-20-032734-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120032739/0001209191-20-032739-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120032741/0001209191-20-032741-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120032745/0001209191-20-032745-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120032747/0001209191-20-032747-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120039189/0001209191-20-039189-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120039194/0001209191-20-039194-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040673/0001209191-20-040673-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040681/0001209191-20-040681-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040684/0001209191-20-040684-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040693/0001209191-20-040693-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120042208/0001209191-20-042208-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050141/0001209191-20-050141-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050214/0001209191-20-050214-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050301/0001209191-20-050301-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053110/0001209191-20-053110-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053118/0001209191-20-053118-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053127/0001209191-20-053127-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053136/0001209191-20-053136-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120055051/0001209191-20-055051-index.htm |
| 2020-10-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120056071/0001209191-20-056071-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1567514/000120919120057347/0001209191-20-057347-index.htm |
| 2019-09-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1567514/999999999519002080/9999999995-19-002080-index.htm |
| 2019-07-05 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1567514/999999999719006061/9999999997-19-006061-index.htm |
Intra-Cellular Therapies, Inc (ITCI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intra-Cellular Therapies, Inc (ITCI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 504%Institutional Ownership: 8606%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-06-12 | Christopher D Alafi | Director | Buy | 95,069.00 | 11.70 | 1,112,307.30 | 111,295.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119037205/0001209191-19-037205-index.htm |
| 2020-01-09 | Andrew Satlin | EVP and Chief Medical Officer | Sell | 11,573.00 | 26.16 | 302,749.68 | 11,338.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003150/0001209191-20-003150-index.htm |
| 2018-12-10 | Sharon Mates | Chairman, President & CEO | Buy | 50,000.00 | 1.50 | 75,000.00 | 1,138,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118062061/0001209191-18-062061-index.htm |
| 2019-01-02 | Sharon Mates | Chairman, President & CEO | Sell | 17,478.00 | 11.09 | 193,831.02 | 1,138,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001611/0001209191-19-001611-index.htm |
| 2019-01-07 | Sharon Mates | Chairman, President & CEO | Sell | 6,604.00 | 12.43 | 82,087.72 | 1,138,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002964/0001209191-19-002964-index.htm |
| 2018-12-31 | RICHARD A LERNER | Director | Buy | 1,207.00 | 11.39 | 13,747.73 | 11,430.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001532/0001209191-19-001532-index.htm |
| 2020-01-02 | Sharon Mates | Chairman, President & CEO | Sell | 56.00 | 34.30 | 1,920.80 | 1,144,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2020-01-06 | Sharon Mates | Chairman, President & CEO | Sell | 37,659.00 | 30.39 | 1,144,457.01 | 1,144,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm |
| 2020-01-02 | Sharon Mates | Chairman, President & CEO | Sell | 3,000.00 | 33.25 | 99,750.00 | 1,144,763.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2019-01-04 | Sharon Mates | Chairman, President & CEO | Sell | 7,539.00 | 11.82 | 89,110.98 | 1,145,311.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002964/0001209191-19-002964-index.htm |
| 2020-01-02 | Sharon Mates | Chairman, President & CEO | Sell | 10,722.00 | 32.43 | 347,714.46 | 1,147,763.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2019-01-03 | Sharon Mates | Chairman, President & CEO | Buy | 11,258.00 | 1,149,965.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001611/0001209191-19-001611-index.htm | ||
| 2019-01-04 | Sharon Mates | Chairman, President & CEO | Sell | 38,059.00 | 11.38 | 433,111.42 | 1,152,850.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002964/0001209191-19-002964-index.htm |
| 2020-01-03 | Sharon Mates | Chairman, President & CEO | Buy | 11,258.00 | 1,155,965.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm | ||
| 2018-12-31 | Sharon Mates | Chairman, President & CEO | Buy | 17,478.00 | 1,156,185.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001611/0001209191-19-001611-index.htm | ||
| 2019-12-31 | Sharon Mates | Chairman, President & CEO | Buy | 17,478.00 | 1,156,185.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm | ||
| 2020-01-02 | Sharon Mates | Chairman, President & CEO | Sell | 3,700.00 | 31.85 | 117,845.00 | 1,158,485.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2019-12-31 | Sharon Mates | Chairman, President & CEO | Buy | 6,000.00 | 2.74 | 16,440.00 | 1,162,185.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm |
| 2020-11-04 | Sharon Mates | Chairman, President & CEO | Sell | 50,000.00 | 25.00 | 1,250,000.00 | 1,163,392.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120057347/0001209191-20-057347-index.htm |
| 2020-01-06 | Sharon Mates | Chairman, President & CEO | Sell | 7,939.00 | 29.78 | 236,423.42 | 1,182,366.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm |
| 2019-01-03 | Sharon Mates | Chairman, President & CEO | Buy | 34,340.00 | 1,184,305.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001611/0001209191-19-001611-index.htm | ||
| 2020-01-08 | Sharon Mates | Chairman, President & CEO | Buy | 41,895.00 | 1,186,602.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm | ||
| 2020-01-03 | Sharon Mates | Chairman, President & CEO | Buy | 34,340.00 | 1,190,305.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001465/0001209191-20-001465-index.htm | ||
| 2019-01-04 | Sharon Mates | Chairman, President & CEO | Buy | 6,604.00 | 1,190,909.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002964/0001209191-19-002964-index.htm | ||
| 2020-01-09 | Sharon Mates | Chairman, President & CEO | Sell | 41,895.00 | 26.16 | 1,095,973.20 | 1,204,707.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003146/0001209191-20-003146-index.htm |
| 2020-01-24 | Sharon Mates | Chairman, President & CEO | Buy | 18,008.00 | 1,222,715.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005265/0001209191-20-005265-index.htm | ||
| 2020-01-08 | Sharon Mates | Chairman, President & CEO | Buy | 44,000.00 | 2.74 | 120,560.00 | 1,230,602.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm |
| 2020-01-08 | Sharon Mates | Chairman, President & CEO | Buy | 16,000.00 | 2.74 | 43,840.00 | 1,246,602.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002646/0001209191-20-002646-index.htm |
| 2019-10-15 | Mark Neumann | EVP, Chief Commercial Officer | Buy | 13,448.00 | 13,448.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119053435/0001209191-19-053435-index.htm | ||
| 2020-01-02 | Michael Halstead | EVP and General Counsel | Sell | 4,959.00 | 32.43 | 160,820.37 | 1,416.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm |
| 2020-05-13 | JOEL S MARCUS | Director | Sell | 7,297.00 | 20.63 | 150,537.11 | 14,374.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120029009/0001209191-20-029009-index.htm |
| 2019-06-12 | Christopher D Alafi | Director | Buy | 16,226.00 | 10.91 | 177,025.66 | 16,226.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119037205/0001209191-19-037205-index.htm |
| 2019-01-02 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Sell | 4,834.00 | 11.10 | 53,657.40 | 16,861.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001588/0001209191-19-001588-index.htm |
| 2019-06-12 | Christopher D Alafi | Director | Buy | 58,705.00 | 12.00 | 704,460.00 | 170,000.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119037205/0001209191-19-037205-index.htm |
| 2019-01-02 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 7,807.00 | 11.09 | 86,579.63 | 17,032.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001562/0001209191-19-001562-index.htm |
| 2019-01-07 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 3,108.00 | 12.42 | 38,601.36 | 17,032.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002960/0001209191-19-002960-index.htm |
| 2020-01-06 | Michael Halstead | EVP and General Counsel | Sell | 3,945.00 | 29.80 | 117,561.00 | 17,704.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002637/0001209191-20-002637-index.htm |
| 2020-01-06 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 17,591.00 | 30.40 | 534,766.40 | 18,800.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002634/0001209191-20-002634-index.htm |
| 2020-01-09 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 19,638.00 | 26.16 | 513,730.08 | 18,800.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003142/0001209191-20-003142-index.htm |
| 2019-01-02 | Michael Halstead | EVP and General Counsel | Sell | 7,807.00 | 11.09 | 86,579.63 | 191.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001606/0001209191-19-001606-index.htm |
| 2019-01-07 | Michael Halstead | EVP and General Counsel | Sell | 3,108.00 | 12.42 | 38,601.36 | 191.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002962/0001209191-19-002962-index.htm |
| 2020-01-02 | Michael Halstead | EVP and General Counsel | Sell | 25.00 | 34.30 | 857.50 | 191.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm |
| 2020-01-06 | Michael Halstead | EVP and General Counsel | Sell | 17,513.00 | 30.46 | 533,445.98 | 191.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002637/0001209191-20-002637-index.htm |
| 2020-01-09 | Michael Halstead | EVP and General Counsel | Sell | 19,638.00 | 26.16 | 513,730.08 | 191.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003144/0001209191-20-003144-index.htm |
| 2019-01-03 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Buy | 2,649.00 | 19,510.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001588/0001209191-19-001588-index.htm | ||
| 2019-12-23 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 5,432.00 | 25.50 | 138,516.00 | 19,800.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119061920/0001209191-19-061920-index.htm |
| 2020-01-02 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 25.00 | 34.30 | 857.50 | 19,800.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm |
| 2020-01-02 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 1,000.00 | 33.28 | 33,280.00 | 19,825.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm |
| 2020-01-08 | Michael Halstead | EVP and General Counsel | Buy | 19,638.00 | 19,829.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002637/0001209191-20-002637-index.htm | ||
| 2019-01-04 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 1,742.00 | 11.84 | 20,625.28 | 20,140.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002960/0001209191-19-002960-index.htm |
| 2020-01-02 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 4,982.00 | 32.46 | 161,715.72 | 20,825.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm |
| 2020-01-02 | Michael Halstead | EVP and General Counsel | Sell | 1,200.00 | 33.23 | 39,876.00 | 216.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm |
| 2019-01-03 | Michael Halstead | EVP and General Counsel | Buy | 16,160.00 | 21,649.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001606/0001209191-19-001606-index.htm | ||
| 2020-01-03 | Michael Halstead | EVP and General Counsel | Buy | 16,160.00 | 21,649.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm | ||
| 2018-12-31 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Buy | 9,322.00 | 21,695.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001588/0001209191-19-001588-index.htm | ||
| 2019-01-04 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 19,716.00 | 11.42 | 225,156.72 | 21,882.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002960/0001209191-19-002960-index.htm |
| 2019-01-03 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 5,298.00 | 22,330.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001562/0001209191-19-001562-index.htm | ||
| 2020-01-08 | Andrew Satlin | EVP and Chief Medical Officer | Buy | 22,911.00 | 22,911.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003150/0001209191-20-003150-index.htm | ||
| 2020-01-03 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 5,298.00 | 24,098.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm | ||
| 2019-01-04 | Michael Halstead | EVP and General Counsel | Buy | 3,108.00 | 24,757.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002962/0001209191-19-002962-index.htm | ||
| 2018-12-31 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 7,807.00 | 24,839.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001562/0001209191-19-001562-index.htm | ||
| 2019-02-27 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 1,000.00 | 15.00 | 15,000.00 | 25,232.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119015224/0001209191-19-015224-index.htm |
| 2019-12-23 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 9,600.00 | 25.50 | 244,800.00 | 25,232.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119061920/0001209191-19-061920-index.htm |
| 2020-01-02 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 1,800.00 | 31.84 | 57,312.00 | 25,807.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm |
| 2019-02-27 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 10,000.00 | 2.74 | 27,400.00 | 25,832.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119015224/0001209191-19-015224-index.htm |
| 2019-02-27 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 400.00 | 2.74 | 1,096.00 | 26,232.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119015224/0001209191-19-015224-index.htm |
| 2020-01-24 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 8,043.00 | 26,843.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005268/0001209191-20-005268-index.htm | ||
| 2019-01-07 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Sell | 592.00 | 12.29 | 7,275.68 | 27,068.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002957/0001209191-19-002957-index.htm |
| 2019-12-31 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 7,807.00 | 27,607.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm | ||
| 2020-01-08 | Mark Neumann | EVP, Chief Commercial Officer | Buy | 20,947.00 | 27,621.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003148/0001209191-20-003148-index.htm | ||
| 2019-01-04 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Sell | 2,184.00 | 11.81 | 25,793.04 | 27,660.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002957/0001209191-19-002957-index.htm |
| 2020-10-16 | Mark Neumann | EVP, Chief Commercial Officer | Sell | 6,792.00 | 26.80 | 182,025.60 | 28,120.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120055051/0001209191-20-055051-index.htm |
| 2020-06-25 | JOEL S MARCUS | Director | Buy | 14,005.00 | 28,379.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120039194/0001209191-20-039194-index.htm | ||
| 2019-01-04 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Sell | 7,380.00 | 11.37 | 83,910.60 | 29,844.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002957/0001209191-19-002957-index.htm |
| 2018-12-06 | Robert E Davis | SVP, Chief Scientific Officer | Sell | 899.00 | 13.53 | 12,163.47 | 30,256.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118061525/0001209191-18-061525-index.htm |
| 2018-12-04 | Robert E Davis | SVP, Chief Scientific Officer | Buy | 1,758.00 | 31,155.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118061525/0001209191-18-061525-index.htm | ||
| 2019-01-04 | Michael Halstead | EVP and General Counsel | Sell | 5,398.00 | 11.80 | 63,696.40 | 3,299.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002962/0001209191-19-002962-index.htm |
| 2019-06-28 | Christopher D Alafi | Director | Buy | 1,117.00 | 12.98 | 14,498.66 | 341,223.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040359/0001209191-19-040359-index.htm |
| 2019-09-30 | Christopher D Alafi | Director | Buy | 1,941.00 | 7.47 | 14,499.27 | 343,164.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051848/0001209191-19-051848-index.htm |
| 2019-12-31 | Christopher D Alafi | Director | Buy | 422.00 | 34.31 | 14,478.82 | 343,586.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001462/0001209191-20-001462-index.htm |
| 2020-03-31 | Christopher D Alafi | Director | Buy | 1,024.00 | 15.37 | 15,738.88 | 344,610.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022764/0001209191-20-022764-index.htm |
| 2020-06-30 | Christopher D Alafi | Director | Buy | 613.00 | 25.67 | 15,735.71 | 345,223.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040673/0001209191-20-040673-index.htm |
| 2020-09-30 | Christopher D Alafi | Director | Buy | 613.00 | 25.66 | 15,729.58 | 345,836.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053110/0001209191-20-053110-index.htm |
| 2019-01-02 | Robert E Davis | SVP, Chief Scientific Officer | Sell | 4,834.00 | 11.11 | 53,705.74 | 34,744.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001584/0001209191-19-001584-index.htm |
| 2019-12-23 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 9,600.00 | 2.74 | 26,304.00 | 34,832.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119061920/0001209191-19-061920-index.htm |
| 2020-10-15 | Mark Neumann | EVP, Chief Commercial Officer | Buy | 13,448.00 | 34,912.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120055051/0001209191-20-055051-index.htm | ||
| 2019-01-03 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Buy | 16,160.00 | 35,670.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001588/0001209191-19-001588-index.htm | ||
| 2020-01-06 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 3,867.00 | 29.80 | 115,236.60 | 36,391.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002634/0001209191-20-002634-index.htm |
| 2019-01-04 | Kimberly E. Vanover | SVP, Early Stage Clinical Dev. | Buy | 1,554.00 | 37,224.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002957/0001209191-19-002957-index.htm | ||
| 2019-01-03 | Robert E Davis | SVP, Chief Scientific Officer | Buy | 2,649.00 | 37,393.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001584/0001209191-19-001584-index.htm | ||
| 2020-01-08 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 19,638.00 | 38,438.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120002634/0001209191-20-002634-index.htm | ||
| 2019-01-03 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 16,160.00 | 38,490.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001562/0001209191-19-001562-index.htm | ||
| 2020-05-14 | JOEL S MARCUS | Director | Sell | 9,602.00 | 20.04 | 192,424.08 | 39,140.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120029818/0001209191-20-029818-index.htm |
| 2018-12-31 | Robert E Davis | SVP, Chief Scientific Officer | Buy | 9,322.00 | 39,578.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001584/0001209191-19-001584-index.htm | ||
| 2018-12-31 | RORY B RIGGS | Director | Buy | 1,273.00 | 11.39 | 14,499.47 | 40,057.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001545/0001209191-19-001545-index.htm |
| 2020-01-03 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 16,160.00 | 40,258.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001467/0001209191-20-001467-index.htm | ||
| 2019-05-14 | Christopher D Alafi | Director | Buy | 100,000.00 | 12.56 | 1,256,350.00 | 4,053,270.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119030123/0001209191-19-030123-index.htm |
| 2019-03-31 | RORY B RIGGS | Director | Buy | 1,190.00 | 12.18 | 14,494.20 | 41,247.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022715/0001209191-19-022715-index.htm |
| 2019-01-04 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 3,108.00 | 41,598.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002960/0001209191-19-002960-index.htm | ||
| 2019-05-29 | JOEL S MARCUS | Director | Buy | 20,000.00 | 12.45 | 249,000.00 | 41,671.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119033664/0001209191-19-033664-index.htm |
| 2019-08-30 | Christopher D Alafi | Director | Buy | 125,000.00 | 8.52 | 1,065,212.50 | 4,188,270.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119048307/0001209191-19-048307-index.htm |
| 2019-09-10 | Christopher D Alafi | Director | Buy | 3,549.00 | 8.98 | 31,870.02 | 4,191,819.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119049172/0001209191-19-049172-index.htm |
| 2019-06-28 | RORY B RIGGS | Director | Buy | 1,117.00 | 12.98 | 14,498.66 | 42,364.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040399/0001209191-19-040399-index.htm |
| 2019-09-10 | Christopher D Alafi | Director | Buy | 155,116.00 | 9.59 | 1,487,562.44 | 4,346,935.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119049172/0001209191-19-049172-index.htm |
| 2019-01-04 | Robert E Davis | SVP, Chief Scientific Officer | Sell | 2,702.00 | 11.80 | 31,883.60 | 43,989.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002955/0001209191-19-002955-index.htm |
| 2019-09-30 | RORY B RIGGS | Director | Buy | 1,941.00 | 7.47 | 14,499.27 | 44,305.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051861/0001209191-19-051861-index.htm |
| 2019-12-31 | RORY B RIGGS | Director | Buy | 422.00 | 34.31 | 14,478.82 | 44,727.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001463/0001209191-20-001463-index.htm |
| 2020-03-31 | RORY B RIGGS | Director | Buy | 1,024.00 | 15.37 | 15,738.88 | 45,751.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022748/0001209191-20-022748-index.htm |
| 2019-09-10 | Christopher D Alafi | Director | Buy | 320,095.00 | 10.58 | 3,386,605.10 | 4,667,030.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119049172/0001209191-19-049172-index.htm |
| 2019-01-04 | Robert E Davis | SVP, Chief Scientific Officer | Sell | 6,862.00 | 11.33 | 77,746.46 | 46,691.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002955/0001209191-19-002955-index.htm |
| 2019-09-10 | Christopher D Alafi | Director | Buy | 6,240.00 | 11.00 | 68,640.00 | 4,673,270.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119049172/0001209191-19-049172-index.htm |
| 2020-09-11 | Christopher D Alafi | Director | Buy | 21,000.00 | 28.08 | 589,680.00 | 4,694,270.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050141/0001209191-20-050141-index.htm |
| 2020-09-14 | Christopher D Alafi | Director | Buy | 49,500.00 | 29.60 | 1,465,200.00 | 4,743,770.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050301/0001209191-20-050301-index.htm |
| 2020-05-11 | JOEL S MARCUS | Director | Sell | 50,000.00 | 19.95 | 997,500.00 | 48,742.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120029009/0001209191-20-029009-index.htm |
| 2018-12-31 | NOSTRAND ROBERT L VAN | Director | Buy | 512.00 | 11.39 | 5,831.68 | 4,955.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001553/0001209191-19-001553-index.htm |
| 2020-09-09 | Lawrence J. Hineline | SVP of Finance CFO | Buy | 26,983.00 | 12.73 | 343,493.59 | 50,017.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050214/0001209191-20-050214-index.htm |
| 2019-01-03 | Robert E Davis | SVP, Chief Scientific Officer | Buy | 16,160.00 | 53,553.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001584/0001209191-19-001584-index.htm | ||
| 2019-03-31 | NOSTRAND ROBERT L VAN | Director | Buy | 478.00 | 12.18 | 5,822.04 | 5,433.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022725/0001209191-19-022725-index.htm |
| 2019-01-03 | Michael Halstead | EVP and General Counsel | Buy | 5,298.00 | 5,489.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001606/0001209191-19-001606-index.htm | ||
| 2020-01-03 | Michael Halstead | EVP and General Counsel | Buy | 5,298.00 | 5,489.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm | ||
| 2019-06-28 | NOSTRAND ROBERT L VAN | Director | Buy | 449.00 | 12.98 | 5,828.02 | 5,882.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040463/0001209191-19-040463-index.htm |
| 2020-06-25 | RORY B RIGGS | Director | Buy | 14,005.00 | 59,756.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120039189/0001209191-20-039189-index.htm | ||
| 2020-06-30 | RORY B RIGGS | Director | Buy | 613.00 | 25.67 | 15,735.71 | 60,369.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040681/0001209191-20-040681-index.htm |
| 2020-09-30 | RORY B RIGGS | Director | Buy | 613.00 | 25.66 | 15,729.58 | 60,982.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053127/0001209191-20-053127-index.htm |
| 2020-01-02 | Michael Halstead | EVP and General Counsel | Sell | 1,623.00 | 31.83 | 51,660.09 | 6,375.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm |
| 2019-09-30 | NOSTRAND ROBERT L VAN | Director | Buy | 780.00 | 7.47 | 5,826.60 | 6,662.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051853/0001209191-19-051853-index.htm |
| 2019-10-16 | Mark Neumann | EVP, Chief Commercial Officer | Sell | 6,774.00 | 8.25 | 55,885.50 | 6,674.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119053435/0001209191-19-053435-index.htm |
| 2018-10-22 | RICHARD A LERNER | Director | Buy | 12,500.00 | 1.50 | 18,750.00 | 66,911.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118056061/0001209191-18-056061-index.htm |
| 2019-03-31 | RICHARD A LERNER | Director | Buy | 1,128.00 | 12.18 | 13,739.04 | 68,039.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022712/0001209191-19-022712-index.htm |
| 2019-12-31 | NOSTRAND ROBERT L VAN | Director | Buy | 170.00 | 34.31 | 5,832.70 | 6,832.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001464/0001209191-20-001464-index.htm |
| 2019-06-28 | RICHARD A LERNER | Director | Buy | 1,059.00 | 12.98 | 13,745.82 | 69,098.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119040436/0001209191-19-040436-index.htm |
| 2019-09-30 | RICHARD A LERNER | Director | Buy | 1,840.00 | 7.47 | 13,744.80 | 70,938.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119051857/0001209191-19-051857-index.htm |
| 2019-12-31 | RICHARD A LERNER | Director | Buy | 400.00 | 34.31 | 13,724.00 | 71,338.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120003756/0001209191-20-003756-index.htm |
| 2020-03-31 | RICHARD A LERNER | Director | Buy | 975.00 | 15.37 | 14,985.75 | 72,313.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022760/0001209191-20-022760-index.htm |
| 2020-03-31 | NOSTRAND ROBERT L VAN | Director | Buy | 460.00 | 15.37 | 7,070.20 | 7,292.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120022753/0001209191-20-022753-index.htm |
| 2018-12-31 | Christopher D Alafi | Director | Buy | 1,273.00 | 11.39 | 14,499.47 | 748,916.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001513/0001209191-19-001513-index.htm |
| 2019-03-31 | Christopher D Alafi | Director | Buy | 1,190.00 | 12.18 | 14,494.20 | 750,106.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119022737/0001209191-19-022737-index.htm |
| 2020-06-30 | NOSTRAND ROBERT L VAN | Director | Buy | 275.00 | 25.67 | 7,059.25 | 7,567.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040693/0001209191-20-040693-index.htm |
| 2020-09-30 | NOSTRAND ROBERT L VAN | Director | Buy | 276.00 | 25.66 | 7,082.16 | 7,843.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053136/0001209191-20-053136-index.htm |
| 2018-11-12 | JOEL S MARCUS | Director | Sell | 7,000.00 | 17.94 | 125,580.00 | 78,742.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118058348/0001209191-18-058348-index.htm |
| 2018-12-31 | Michael Halstead | EVP and General Counsel | Buy | 7,807.00 | 7,998.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119001606/0001209191-19-001606-index.htm | ||
| 2019-12-31 | Michael Halstead | EVP and General Counsel | Buy | 7,807.00 | 7,998.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120001468/0001209191-20-001468-index.htm | ||
| 2020-09-09 | Lawrence J. Hineline | SVP of Finance CFO | Sell | 41,983.00 | 31.14 | 1,307,350.62 | 8,034.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120050214/0001209191-20-050214-index.htm |
| 2020-01-24 | Michael Halstead | EVP and General Counsel | Buy | 8,043.00 | 8,234.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120005270/0001209191-20-005270-index.htm | ||
| 2018-11-09 | JOEL S MARCUS | Director | Sell | 25,000.00 | 18.24 | 456,000.00 | 85,742.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919118058348/0001209191-18-058348-index.htm |
| 2019-01-04 | Michael Halstead | EVP and General Counsel | Sell | 16,060.00 | 11.34 | 182,120.40 | 8,697.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919119002962/0001209191-19-002962-index.htm |
| 2020-05-11 | RICHARD A LERNER | Director | Sell | 3,500.00 | 20.50 | 71,750.00 | 93,813.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120028898/0001209191-20-028898-index.htm |
| 2020-06-30 | RICHARD A LERNER | Director | Buy | 584.00 | 25.67 | 14,991.28 | 94,397.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120040684/0001209191-20-040684-index.htm |
| 2020-09-30 | RICHARD A LERNER | Director | Buy | 584.00 | 25.66 | 14,985.44 | 94,981.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120053118/0001209191-20-053118-index.htm |
| 2020-05-11 | RICHARD A LERNER | Director | Buy | 25,000.00 | 2.74 | 68,500.00 | 97,313.00 | https://www.sec.gov/Archives/edgar/data/1567514/000120919120028898/0001209191-20-028898-index.htm |